Evidence map›Paper›PMID 41003874›Full record

ArticleDiscover oncology2025

Amyloid precursor protein accumulation in glioblastoma is associated with altered synaptic dynamics and immune suppression.

Tyrel R Porter, Mikhail Inyushin, Lilia Kucheryavykh

Abstract read
In one paragraph

Article in Discover oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Astrocytoma-Specific Prognostic Associations of Amyloid-Related Biological Processes.Pathophysiology : the official journal of the International Society for Pathophysiology · 2026
    Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Tyrel R PorterDepartment of Biochemistry, Universidad Central del Caribe, Bayamón, PR, 00956, USA. 122tporter@uccaribe.edu.ORCID https://orcid.org/0009-0003-1413-2100
Mikhail InyushinDepartment of Physiology, Universidad Central del Caribe, Bayamón, PR, 00956, USA.
Lilia KucheryavykhDepartment of Biochemistry, Universidad Central del Caribe, Bayamón, PR, 00956, USA.

Funding

Pyk2 inhibition mitigates immunosuppressive environment and enhances therapeutic response to immune checkpoint inhibitors in GBMR16GM153522 · NIGMS · UNIVERSIDAD CENTRAL DEL CARIBE · PI Lilia Kucheryavykh · 2024 to 2026
$393k
Pyk2 regulates extracellular vesicles release in GBM cells and modulates activation of tumor infiltrating myeloid cellsR15CA287203 · NCI · UNIVERSIDAD CENTRAL DEL CARIBE · PI KUCHERYAVYKH, LILIA · 2024 to 2024
$382k
NCI NIH HHS R15 CA287203NIGMS NIH HHS R16 GM153522NIH HHS 1R15CA287203NIH HHS 1R16GM153522
6 · The paper itself

Abstract

Increased amyloid precursor protein (APP), including both mRNA and protein expression, has been linked to glioblastoma (GBM) yet the physiological effects are poorly understood. In this study, we investigated the relationship between APP protein abundance and mRNA expression in GBM. Gene set enrichment analysis revealed significant positive enrichment of neuron projection and synaptic junction gene sets from Gene Ontology. Additionally, several immune-related processes were negatively enriched, suggesting a broad immune suppression associated with increased presence of APP. These findings suggest a multi-faceted role of APP, linking its presence to modulation of synaptic activity as well as the immune microenvironment in GBM tumors.

Identifiers

PMID41003874
PMCPMC12474803

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.